Lixia X. Ma
Changchun, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Fovinaciclib for First-Line Therapy of Advanced Breast Cancer: A Randomized Clinical Trial.
Journal: JAMA oncology
Published: June 01, 2026
Updated survival outcomes of SYHX2011 versus albumin-bound paclitaxel in advanced breast cancer: A randomized double-blind phase III trial.
Journal: Biomolecules & biomedicine
Published: April 23, 2026
Albumin-Bound Paclitaxel (SYHX2011) in Patients with Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Phase III Study.
Journal: Cancer communications (London, England)
Published: December 09, 2025
Durvalumab Consolidation Treatment Following Concurrent Chemoradiotherapy in Limited-Stage SCLC: ADRIATIC China Subgroup Analysis.
Journal: JTO clinical and research reports
Published: November 07, 2025
Real-world evidence on the efficacy, safety, and biomarkers of immunotherapy combined with radiotherapy in limited-stage small cell lung cancer.
Journal: Journal of thoracic disease
Published: October 24, 2025
A clinically translatable 2.5D lung adenocarcinoma organoid platform derived from malignant pleural effusions for precision drug screening and tumor-immune-stromal modeling.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 05, 2025
The pathogenic mutations in smokers with non-small cell lung cancer: a next-generation sequencing study.
Journal: Translational lung cancer research
Published: March 07, 2025
PKM1 Regulates the Expression of Autophagy and Neuroendocrine Markers in Small Cell Lung Cancer
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: November 04, 2024
Anti-PD-L1 envafolimab combined with anti-VEGF suvemcitug in pretreated solid tumors and hepatocellular carcinoma: an open-label phase II study with safety run-in stage.
Journal: Investigational new drugs
Published: September 24, 2024
Partial intestinal obstruction caused by duodenal obstruction by the superior mesenteric artery and abdominal aorta in a middle-aged woman: A case report.
Journal: Heliyon
Published: January 17, 2024
Long noncoding RNA TFAP2A AS1 exerts promotive effects in non small cell lung cancer progression via controlling the microRNA 548a 3p/CDK4 axis.
Journal: Oncology research
Published: May 31, 2022
Long noncoding RNA TFAP2A-AS1 exerts promotive effects in non-small cell lung cancer progression via controlling the microRNA-548a-3p/CDK4 axis as a competitive endogenous RNA.
Journal: Oncology research
Published: April 04, 2022
Last Updated: 09/26/2026